Specific 17-Beta-Hydroxywithanolides Sensitize Cancer Cells to Apoptosis in Response to Toll-Like Receptor (Tlr)

Technology #ua16-001

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Researchers
James McMahon
Leidos Biomedical Research Inc. and NCI Frederick
Curtis Henrich
Leidos Biomedical Research Inc. and NCI Frederick
Alan Brooks
Leidos Biomedical Research Inc. and NCI Frederick
Poonam Tewary
Leidos Biomedical Research Inc. and NCI Frederick
Thomas Sayers
Leidos Biomedical Research Inc. and NCI Frederick
Kithsiri Wijeratne
Assistant Research Scientist, Arid Lands Studies
Yaming Xu
Research Associate, Natural Resources and the Environment
Leslie Gunatilaka
Professor, Natural Resources and the Environment
Managed By
Tod McCauley
Sr. Licensing Manager (520) 626-7916

Title: Specific 17-beta-hydroxywithanolides Sensitize Cancer Cells to Apoptosis in Response to Toll-like Receptor (TLR)

 

Invention: The invention relates to compounds that promoye cancer cell death by increasing cell signalling through the extrinsic apoptosis pathway.

 

Licensing Manager: Tod McCauley

todm@tla.arizona.edu

(520) 626-7916